<DOC>
	<DOCNO>NCT02815657</DOCNO>
	<brief_summary>The purpose study investigate potential interaction SP2086 Valsartan multiple oral dos treatment healthy adult volunteer .</brief_summary>
	<brief_title>The Drug-drug Interaction SP2086 Valsartan</brief_title>
	<detailed_description>This open-label ( volunteer know name treatment assign ) single-center cross-over study SP2086 Valsartan healthy adult volunteer . All subject randomize two group , drug administer accord AB BA sequence , subject must complete two stage ( A B ) . The A sequence Valsartan take 160mg qd Days1-Day12 ; SP2086 administer orally ( mouth ) 200mg Days 8-Day12.The B sequence SP2086 take 200mg qd dose Days 8-Day12.There 6 day washout period two stage . The whole study need 31 day .</detailed_description>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Healthy volunteer body mass index ( BMI ) 19 24 Kg/m2 Had sign inform consent . Have abnormal lab examination result change clinical significance . History current clinically significant medical illness determine Investigator . Have family history thyroid cancer , submandibular gland cancer long QT syndrome Known allergy SP2086 Glyburide excipients formulation SP2086 Glyburide . History use sulfa sulfonylurea DPPIVor GLP1 drug similar structure drug . History severe unconsciousness hypoglycemia History surgery prior screen 6 month . History blood donationâ‰¥400 mL prior screen 3 month participate blood donation , blood transfusion one month . History participate drug medical device prior screen 3 month . Within month screen use prescription drug , overthecounter drug , Chinese herbal medicine ( especially oral antidiabetic drug ) food supplement ( vitamin ) . 2 day randomization , patient ban alcohol , tobacco , reference food drink contain caffeine xanthine , vigorous exercise , factor affect drug absorption , distribution , metabolism excretion . The hepatitis B surface antigen , hepatitis c antibody , HIV antibody syphilis antibody positive . Pregnancy lactation woman , fertility male female willing contraception test . Researchers consider situation may cause participant ca n't finish study bring obvious risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>SP2086</keyword>
	<keyword>Valsartan</keyword>
	<keyword>Drug-drug Interaction</keyword>
</DOC>